Charles River Laboratories Publishes 2023 Corporate Citizenship Report - Seite 2

Charles River is committed to providing an exceptional employee experience in which its people can learn, grow, and make an impact. Employee-focused initiatives include:

• Grew 11 Employee Resource Groups (ERGs) to include nearly 4,000 people, helping to cultivate a sense of belonging and inclusion.
• Demonstrated the Company’s commitment to equity by advancing women in leadership, with women representing 53% of total leadership in 2023 and the composition of women at the Executive Leadership level (VP+) increasing to 42% in 2023.
• Remained focused on employee learning and development as employees globally completed more than 410,000 learning sessions.
• Contributed a total of 29,000 employee volunteer hours in 2023, a company record.

Protect our Planet

Charles River operates responsibly and promotes a sustainable future in the communities where the Company operates. Working towards its environmental goals, Charles River:

• Reduced Scope 1 and 2 global greenhouse gas (GHG) emissions by 37% over the last five years, targeting a 50% reduction by 2030.
• Achieved 92% renewable electricity usage globally, working toward the deployment of 100% renewable electricity across operations by 2030.
• Continued advancing global sustainability capital projects through its annual Sustainability Capital Fund, originally introduced in 2020. As of year-end 2023, the fund has supported $13.5 million in projects.

The 2023 Corporate Citizenship Report was prepared in accordance with the latest Global Reporting Initiative (GRI) Universal Standards, as well as the Sustainability Accounting Standards Board (SASB) Biotechnology and Pharmaceuticals Standard. The report is also aligned with relevant U.N. Sustainable Development Goals (UNSDGs) and recommendations set out by the Task Force on Climate-related Financial Disclosures (TCFD). The TCFD report will be available later in 2024 at www.criver.com.

Visit the Corporate Citizenship section of Charles River’s website to read the 2023 Corporate Citizenship Report in its entirety and learn more about the Company’s ESG disclosures.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240327700198/en/

The Charles River Laboratories International Stock at the time of publication of the news with a fall of -0,12 % to 245USD on Tradegate stock exchange (27. März 2024, 12:13 Uhr).